Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets

As treatment protocols for medulloblastoma (MB) are becoming subgroup-specific, means for reliably distinguishing between its subgroups are a timely need. Currently available methods include immunohistochemical stains, which are subjective and often inconclusive, and molecular techniques—e.g., NanoS...

Descripción completa

Detalles Bibliográficos
Autores principales: Gershanov, Sivan, Madiwale, Shreyas, Feinberg-Gorenshtein, Galina, Vainer, Igor, Nehushtan, Tamar, Michowiz, Shalom, Goldenberg-Cohen, Nitza, Birger, Yehudit, Toledano, Helen, Salmon-Divon, Mali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223061/
https://www.ncbi.nlm.nih.gov/pubmed/34178626
http://dx.doi.org/10.3389/fonc.2021.637482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223061/
https://www.ncbi.nlm.nih.gov/pubmed/34178626
http://dx.doi.org/10.3389/fonc.2021.637482

Ejemplares similares